XML 14 R1.htm IDEA: XBRL DOCUMENT v3.25.0.1
Document And Entity Information - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Feb. 27, 2025
Jun. 30, 2024
Cover [Abstract]      
Document Type 10-K    
Document Period End Date Dec. 31, 2024    
Amendment Flag false    
Trading Symbol SGHT    
Entity Registrant Name SIGHT SCIENCES, INC.    
Entity Central Index Key 0001531177    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Well-known Seasoned Issuer No    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2024    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Shell Company false    
Entity Ex Transition Period false    
Document Fiscal Period Focus FY    
Entity Public Float     $ 243.8
Entity Common Stock, Shares Outstanding   51,332,694  
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity File Number 001-40587    
Entity Tax Identification Number 80-0625749    
Entity Address, Address Line One 4040 Campbell Ave    
Entity Address, Address Line Two Suite 100    
Entity Address, City or Town Menlo Park    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94025    
City Area Code 877    
Local Phone Number 266-1144    
Entity Interactive Data Current Yes    
Title of 12(b) Security Common Stock, par value $0.001    
Security Exchange Name NASDAQ    
Entity Incorporation, State or Country Code DE    
Document Annual Report true    
Document Transition Report false    
Documents Incorporated by Reference

Portions of the Registrant's definitive Proxy Statement relating to its 2024 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year ended December 31, 2024 are incorporated herein by reference in Part III of this Annual Report on Form 10-K.

    
Auditor Name DELOITTE & TOUCHE LLP    
Auditor Location San Jose, California    
Auditor Firm ID 34    
Auditor Opinion

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Sight Sciences, Inc. and subsidiaries (the "Company") as of December 31, 2024 and 2023, the related consolidated statements of operations and comprehensive loss, stockholders' equity, and cash flows, for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America